Netflix Stock: Q2 Earnings Were Much Better Than The Market Thinks — Positive
NFLX Seeking Alpha — July 18, 2025Netflix, Inc.'s latest quarter impressed me, with strong revenue growth in UCAN and growth that went far beyond just currency tailwinds. Subscriber growth and retention remain robust, even after price hikes and with paid sharing and advertising still evolving. I'm cautious about Netflix's push into advertising and sports, fearing these could undermine its core value proposition.
M&A chatter swirls around Union Pacific and Norfolk Southern. This is why a deal makes sense. — Positive
NSC UNP Market Watch — July 18, 2025Buying Norfolk Southern could provide unique benefits to Union Pacific, such as the old Wabash line.
Townsquare (TSQ) Surges 6.9%: Is This an Indication of Further Gains? — Positive
TSQ Zacks Investment Research — July 18, 2025Townsquare (TSQ) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Streaming giant Netflix NASDAQ: NFLX released Q2 2025 results on July 17, beating expectations on both sales and earnings for the seventh consecutive quarter. Despite this, markets weren't jumping for joy.
Watsco Schedules Second Quarter Earnings Call on July 30, 2025 — Neutral
WSO GlobeNewsWire — July 18, 2025MIAMI, July 18, 2025 (GLOBE NEWSWIRE) -- Watsco, Inc. (NYSE: WSO) announced today that it will host its second quarter 2025 conference call on Wednesday, July 30, 2025 at 10:00 a.m. (EDT). Prepared remarks regarding the results will be followed by a question-and-answer session with the senior management team.
Is the Options Market Predicting a Spike in Element Solutions Stock? — Neutral
ESI Zacks Investment Research — July 18, 2025Investors need to pay close attention to ESI stock based on the movements in the options market lately.
EQT to Report Q2 Earnings: Here's What You Need to Know — Negative
EQT Zacks Investment Research — July 18, 2025Margin pressures and pipeline bottlenecks are likely to have weighed on EQT's Q2 earnings.
Coca-Cola's Q2 Earnings on the Deck: A Smart Buy Before the Release? — Negative
KO Zacks Investment Research — July 18, 2025KO's Q2 earnings preview points to solid revenue growth, but margin pressure and global headwinds may cloud the outlook.
The Charles Schwab Corporation (SCHW) Q2 Earnings and Revenues Beat Estimates — Positive
SCHW Zacks Investment Research — July 18, 2025The Charles Schwab Corporation (SCHW) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $1.09 per share. This compares to earnings of $0.73 per share a year ago.
American Express beats Q2 estimates on strong cardholder spending — Positive
AXP Proactive Investors — July 18, 2025American Express Company (NYSE:AXP, ETR:AEC1) reported better-than-expected earnings for the second quarter, driven by robust cardholder spending and demand for its premium products. Earnings per share (EPS) grew 17% year-over-year to $4.08, beating the Wall Street consensus of $3.87 by $0.21.
Why You Shouldn't Bet Against JPMorgan Stock — Positive
JPM Zacks Investment Research — July 18, 2025JPM has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
IBKR Stock Gains on Q2 Earnings Beat, Revenues & Expenses Rise Y/Y — Positive
IBKR Zacks Investment Research — July 18, 2025IBKR Q2 adjusted earnings of $1.51 beat estimates, fueled by customer account growth and surging trading activities.
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? — Positive
OPRX Zacks Investment Research — July 18, 2025OptimizeRx bets on EHR-linked messaging and geo-targeting to stand out, but scaling in a crowded digital health field remains key.
CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake? — Positive
CVS Zacks Investment Research — July 18, 2025CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
Truist Financial Q2 Earnings Lag as Provisions Increase Y/Y — Positive
TFC Zacks Investment Research — July 18, 2025TFC's Q2 earnings hold steady but miss estimates as rising provisions offset revenue gains and cost declines.
TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus — Neutral
TMO Zacks Investment Research — July 18, 2025Thermo Fisher eyes second-quarter 2025 growth with new tech launches in Analytical Instruments and Life-Science Solutions segments.
Lucid (NASDAQ: LCID) saw its shares soar by more than 36% in a single day following the announcement of a high-profile partnership with Uber and autonomous vehicle startup Nuro, marking a potential turning point for the embattled EV maker.
ExxonMobil will now have a new, very familiar partner in its massive project in the deepwaters off the coast of tiny South American nation Guyana after Chevron emerged the winner in a 16-month-long arbitration case on Friday.
Should You Add Edwards Lifesciences Stock to Your Portfolio Now? — Negative
EW Zacks Investment Research — July 18, 2025EW gains traction with surgical tech and TAVR growth, but macro pressures and FX headwinds weigh on margins.
CoreWeave to Set up New Data Center: Overcapacity or Future-Proofing? — Positive
CRWV Zacks Investment Research — July 18, 2025CRWV bets $6 billion on a new AI data center in Lancaster, PA, expanding its 33-site network as demand for compute power surges.
